Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: Prognosis and outcomes

Table 2 Patient demographics

	Combination group (n = 19)	Resection group (n = 54)	P value
Age (yr)	65 (34-77)	52 (27-80)	0.003
Gender (M:F)	17:2	43:11	0.492
Comorbidities	10 (53%)	20 (37%)	0.235
Renal impairment	0 (0%)	2 (3.7%)	1.000
Diabetes mellitus	5 (26.3%)	10 (18.5%)	0.469
Chest infection	1 (5.3%)	3 (5.6%)	1.000
Coronary complications	6 (31.6%)	14 (25.9%)	0.635
Hepatitis B infection	16 (84.2%)	42 (77.8%)	0.745
Hepatitis C infection	2 (10.5%)	2 (3.7%)	0.478
Child-Pugh class A	19	54	1.000
Platelet count (× 109/L)	165 (91-64.5)	177 (86-458)	0.396
ICG (% at 15 min)	11.8 (3-25.7)	9 (3.7-18.2)	0.083
AFP level (ng/mL)	248 (6-38 040)	133 (2-530 600)	0.915
Tumor size (cm)	6 (1.2-14)	6 (1-12.5)	0.782
Tumor number	3 (2-9)	3 (2-9)	0.574

AFP: α-fetoprotein.